iVascular

Discover the first outcomes of the SOL Japan Trial, evaluating #LuminorDCB in femoropopliteal lesions (mean length: 11 cm). At 1-year follow-up, results speak for themselves: ✅ Primary Patency: 94.9% A clear testament to Luminor’s performance and reliability. Not all DCBs are the same. Luminor is the DCB you need. #iVascular #SOLJapanTrial #Endovascular #MedicalInnovation

We are expanding our facilities to keep pace with our continuous growth and to further strengthen our vertically integrated manufacturing model. This new facility represents a key step in increasing capacity, optimizing processes, and ensuring that we continue to deliver the highest standards of quality and reliability. In this interview, our Operations Director, Pau Llado Perez, shares more about this exciting project and what it means for the future of iVascular.

Join us at #SITE2025 in Barcelona! We are excited to take part once again in one of the leading events in endovascular therapy. 📍 Don’t miss our Lunch Symposium Thursday, 16th October | 13:00–14:00 Session 13 - Topics & Speakers: • Is there still place to use BMS? – Dr Lieven Maene • When to use covered stents and which is the best alternative? – Dr Bahaa Nasr • Are there other uses for covered stents? – Dr Fernando Gallardo

We have always known that collaboration is the key to success. #iVascular thrives through strategic partnerships that amplify our impact. Our alliances help us bring our advanced medical solutions to healthcare professionals worldwide. Together, we’re shaping the future of vascular treatment. Thank our partners for being part of this journey. #iVascular #StrategicAlliances #CollaborationForSuccess

Innovation means clarity, control, and confidence. iCover radiopaque markers ensure precise positioning where it matters most, giving physicians the confidence they need in complex procedures. iCover, the art of innovation. #iCover #ArtOfInnovation #CoveredStent

For 10 years, every Angiolite procedure has written a new page in a story of innovation and care and you’ve been at the heart of it. 🫀 Delivering overexpansion and precision to patients around the world. Turning technology into trusted clinical evidence. Transforming lives, like Teresa Codina’s, treated with two Angiolite stents. Here’s to a decade of achievements and to many more ahead. Thank you for being part of this journey! #10YearsCountingOnYou #Angiolite #iVascular #WeStentByYou

It is always a pleasure to welcome our partners to our facilities. This time, we had the honor of hosting 30 Asia Pacific partners at our headquarters for their annual meeting. The theme of the event, “Proud to Belong,” perfectly captured the spirit of the gathering: a strong network of committed professionals who share our mission to advance vascular care and improve patient outcomes worldwide. We extend our sincere thanks to our APAC partners for their trust and dedication. Your contribution is essential to bringing innovative solutions to physicians and patients across the region. 💙🩷 #iVascular #DistributorMeeting

According to the World Heart Federation’s 2025 factsheet, over 6.5 million people die early from heart disease every year, and yet just 30 minutes of exercise a day could help prevent cardiovascular disease. But here’s the catch: 1 in 3 adults are not moving enough. These stats aren’t just numbers; they’re calls to action. Move more. Protect your heart.

At our recent scientific event in Barcelona, Dr Maene (Belgium) and Dr Nasr (France) lead an insightful session on iliac artery treatment. Their shared experiences, treatment algorithms, and perspectives on the use of BMS and covered stents brought great value to the discussion and were highly appreciated by an audience of over 100 participants. 👏 Many thanks to both doctors for their valuable contribution! #iVascular #CIRSE2025 #EndovascularInnovation

Join Dr Eric Ducasse, vascular surgeon from France, as he shares his experience using the TINTIN Technique (Luminor DCB and iVolution pro SES), an innovative approach to treat challenging lesions, minimizing the risks of restenosis and reocclusion.   In this video, Dr Ducasse addresses: ✔️ Which lesions are ideal candidates for the TINTIN Technique ✔️ Why does he selects this method for these cases ✔️ How Luminor DCB and iVolution pro SES contribute to efficiency and success ✔️ Practical recommendations for performing the technique ➡️ https://lnkd.in/d_MAUXZK   #iVascular #TINTINtechnique #Endovascular